COVID-19 Vaccine Pfizer In Final Stages Of Agreement To Supply In India: CEO

• ByStartupStory     |    June 23, 2021

COVID-19 vaccine Pfizer, is in the final stages of an agreement with India to supply anti-COVID-19 vaccines, CEO Dr Albert Bourla said, in the India-US Bio Pharma & Healthcare Summit being organised by the US-India Chamber of Commerce he further added, “My hope is that very soon we will finalise the approval of the product in India by the Indian healthcare authorities as well as the agreement with the government so that we can also start sending vaccines from our side.”

Responding to a question from Dr Naresh Trehan, Chairman of Medanta hospital, Dr Bourla said that “India went through hell” during the COVID-19 pandemic. But the efforts being undertaken by the Indian Government are working very well, he said. He also noted that Pfizer is confident of producing three billion doses of COVID-19 vaccines and another four billion by next year, making it seven billion in all.

The Pfizer CEO said that significant local manufacturing of vaccines that is happening at the Serum Institute of India will provide the backbone of vaccinating the Indian people.

Follow Startup Story